Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Eptacog Beta Efficacy in Children and Adolescents with Hemophilia A or B and Inhibitors: Subset Analysis Suggests Improved Caregiver Capacity to Assess Bleeding Episode Resolution with Subject Age

Blood (2021) 138 (Supplement 1): 3195.

https://doi.org/10.1182/blood-2021-147434

Published: 2021

Journal Articles

Emicizumab-Kxwh for Previously Untreated Patients with Haemophilia: The Conversation Begins

Tiffany Lin Lucas, MD, Shveta Gupta, MBBS, Joanna A. Davis, MD, Fernando F. Corrales-Medina, MD

Blood (2019) 134 (Supplement_1): 2409.

https://doi.org/10.1182/blood-2019-127270

Published: 2019

Journal Articles

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

Nicoletta Machin, MD, Margaret V. Ragni, MD MPH, Lynn M. Malec, MD, Donald Brambilla, PhD, Thomas Coyle, MD, Joanna A. Davis, MD, Annette Drygalski, Andra H James, MD MPH, Shawn M Jobe, MD PhD, Barbara A. Konkle, MD, Peter Kouides, MD, Philip Kuriakose, MD, Alice D. Ma, MD, Elaine M. Majerus, MD PhD, Danielle Nance, MD, Anne T. Neff, MD, Claire S. Philipp, MD, Tzu-Fei Wang, MD, Hassan M. Yaish, MD

Blood (2015) 126 (23): 4694.

https://doi.org/10.1182/blood.V126.23.4694.4694

Published: 2015

Journal Articles

Congenital Thrombotic Thrombocytopenia Purpura - Safer Treatment with Plasma-Derived Viral-Attenuated Clotting Factor

Louis M. Aledort, MD, Lisa Boggio, MD, Joanna A. Davis, MD, Cynthia Gauger, MD, Nathan L. Kobrinsky, MD FRCP, Anita Rajasekhar, MD MS, Ralph Shapiro, MD, Marcela Torres, MD, Paula J. Ulsh, RN, BSN

Blood (2015) 126 (23): 3459.

https://doi.org/10.1182/blood.V126.23.3459.3459

Published: 2015

Journal Articles

Natural History Of Inhibitor Recurrence Following Successful Immune Tolerance Induction

Ana G. Antun, MD, Paul Monahan, MD, Marilyn J. Manco-Johnson, MD, Michael Callaghan, MD, Guy Young, MD, Christine Knoll, MD, Shannon Carpenter, MD, MS, Joanna A. Davis, MD, Michael F. Guerrera, MD, Rebecca Kruse-Jarres, MD, MPH, Margaret V. Ragni, MD, MPH, Char Witmer, MD, MSCE, Courtney E. McCracken, PhD, Maralee Kanin, Christine L. Kempton, MD, MSc

Blood (2013) 122 (21): 1106.

https://doi.org/10.1182/blood.V122.21.1106.1106

Published: 2013

NARROW

Eptacog Beta Efficacy in Children and Adolescents with Hemophilia A or B and Inhibitors: Subset Analysis Suggests Improved Caregiver Capacity to Assess Bleeding Episode Resolution with Subject Age

Emicizumab-Kxwh for Previously Untreated Patients with Haemophilia: The Conversation Begins

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

Congenital Thrombotic Thrombocytopenia Purpura - Safer Treatment with Plasma-Derived Viral-Attenuated Clotting Factor

Natural History Of Inhibitor Recurrence Following Successful Immune Tolerance Induction

Email alerts

ASH Publications

American Society of Hematology

Eptacog Beta Efficacy in Children and Adolescents with Hemophilia A or B and Inhibitors: Subset Analysis Suggests Improved Caregiver Capacity to Assess Bleeding Episode Resolution with Subject Age

Emicizumab-Kxwh for Previously Untreated Patients with Haemophilia: The Conversation Begins

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

Congenital Thrombotic Thrombocytopenia Purpura - Safer Treatment with Plasma-Derived Viral-Attenuated Clotting Factor

Natural History Of Inhibitor Recurrence Following Successful Immune Tolerance Induction

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only